Dark

KALA
KALA BIO, Inc. Common Stock
stock NASDAQ

At Close

Jun 5, 2026 3:59:49 PM EDT

2.05USD-8.072%(-0.18)127,595

1.75Bid 2.72Ask 0.97Spread

Pre-market

Jun 4, 2026 9:23:30 AM EDT

2.24USD+0.448%(+0.01)0

After-hours

Jun 5, 2026 4:00:30 PM EDT

2.06USD+0.488%(+0.01)1,033

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

38.11M

CEO

Mark Iwicki

Headquarters

Watertown, Massachusetts, USA

Industry

Drug Manufacturers-Specialty & Generic

Last Split

May 11, 20261for50reverse

OMER XLV

KALA Stats

Avg. Vol. 10 Day

87,852

Avg. Vol. 30 Day

87,807

Employees

Market Cap

38,109,156

Shares Out.

18,589,832

On/Off Exchange

36%/64%

6 Month Beta

2.82

1 Year Beta

2.24

2 Year Beta

1.29

3 Year Beta

1.11

52 Week Low

2.03

52 Week High

1,030.00

SMA50

5.88

SMA200

121.79

1 Week

-8.07%

1 Month

-64.38%

3 Month

-85.26%

6 Month

-95.44%

1 Year

-99.01%

2 Year

-99.38%

5 Year

-99.99%

Profile

kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala's website at www.kalarx.com.

KALA Stock Summary

KALA BIO, Inc. Common Stock (NASDAQ:KALA) stock price today is $2.05, and today's volume is 127,595. KALA is down -8.072% today. The 30 day average volume is 87,807. KALA market cap is 38.11M with 18,589,832 shares outstanding.